Shareholding disclosure

The Goldman Sachs Group, Inc., Corporation Trust Centre

Declared position

7.28%

Threshold

Crossed upwards

Timeline

Published

10.01.2018

Transaction

03.01.2018

Voting rights breakdown

Voting rights acquired7.28%

Voting rights sold0%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAI1800044

Beneficial owner

The Goldman Sachs Group, Inc., Corporation Trust Centre

Declared address

The Goldman Sachs Group, Inc., Corporation Trust Centre, Wilmington, DE 19801

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

The Goldman Sachs Group, Inc., Corporation Trust Centre

Santhera Pharmaceuticals Holding AG10.01.2018TAI1800044

Disclosure summary

The Goldman Sachs Group, Inc., Corporation Trust Centre disclosed a holding in Santhera Pharmaceuticals Holding AG on the acquisition side, published by SIX Exchange Regulation on 10.01.2018, at 7.28% of voting rights. Notice category: Single shareholder.

Disclosed position

7.28%

Voting rights acquired

Voting rights acquired7.28%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

The Goldman Sachs Group, Inc., Corporation Trust Centre disclosed a holding in Santhera Pharmaceuticals Holding AG, published on 10.01.2018.

Publication date10.01.2018

Transaction date03.01.2018

Issuing companySanthera Pharmaceuticals Holding AG

Beneficial ownerThe Goldman Sachs Group, Inc., Corporation Trust Centre

Declared addressThe Goldman Sachs Group, Inc., Corporation Trust Centre, Wilmington, DE 19801

CategorySingle shareholder

Voting rights acquired7.28%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTAI1800044

Source: SIX Exchange Regulation · Publication date: 10.01.2018

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open